The Role of Platelets in Diabetic Kidney Disease

被引：10

作者：

Rustiasari, Ukhti Jamil ^{[1
,2
,3
]}

Roelofs, Joris J. ^{[1
,2
]}

机构：

[1] Univ Amsterdam, Amsterdam UMC, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands

[2] Univ Amsterdam, Amsterdam Cardiovasc Sci, NL-1105 AZ Amsterdam, Netherlands

[3] Univ Islam Indonesia, Fac Med, Dept Anat Pathol, Yogyakarta 55584, Indonesia

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2022年 / 23卷 / 15期

关键词：

diabetes; diabetic kidney disease; diabetic nephropathy; platelets; platelet activation; biomarker; antiplatelet; SOLUBLE CD40 LIGAND; DRUG DILAZEP DIHYDROCHLORIDE; PLASMA BETA-THROMBOGLOBULIN; GLOMERULAR MESANGIAL CELL; FIBROBLAST-GROWTH-FACTOR; CHRONIC-RENAL-FAILURE; BERAPROST SODIUM; ACTIVATING-FACTOR; P-SELECTIN; ADHESION MOLECULES;

D O I：

10.3390/ijms23158270

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Diabetic kidney disease (DKD) is among the most common microvascular complications in patients with diabetes, and it currently accounts for the majority of end-stage kidney disease cases worldwide. The pathogenesis of DKD is complex and multifactorial, including systemic and intra-renal inflammatory and coagulation processes. Activated platelets play a pivotal role in inflammation, coagulation, and fibrosis. Mounting evidence shows that platelets play a role in the pathogenesis and progression of DKD. The potentially beneficial effects of antiplatelet agents in preventing progression of DKD has been studied in animal models and clinical trials. This review summarizes the current knowledge on the role of platelets in DKD, including the potential therapeutic effects of antiplatelet therapies.

引用

页数：35

共 50 条

[41] Prorenin/renin and their receptors - a potential role in diabetic kidney disease
Czekalski, Stanislaw
[J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2008, 17 (02): : 123 - 128
[42] What is the role of renin inhibition in the treatment of diabetic kidney disease?
Radko Komers
[J]. Current Diabetes Reports, 2009, 9 : 447 - 452
[43] PLATELETS AND DIABETIC VASCULAR-DISEASE
PATON, RC
PASSA, P
[J]. DIABETES & METABOLISM, 1983, 9 (04): : 306 - 312
[44] The Role of Autophagy in Type 2 Diabetic Kidney Disease Management
Tseng, Che-Hao
Shah, Kavya M.
Chiu, I-Jen
Hsiao, Li-Li
[J]. CELLS, 2023, 12 (23)
[45] Role of Oxidative Stress and Inflammatory Factors in Diabetic Kidney Disease
Aghadavod, Esmat
Khodadadi, Samaneh
Baradaran, Azar
Nasri, Parto
Bahmani, Mahmood
Rafieian-Kopaei, Mahmoud
[J]. IRANIAN JOURNAL OF KIDNEY DISEASES, 2016, 10 (06) : 337 - 343
[46] The Role of the Epidermal Growth Factor Receptor in Diabetic Kidney Disease
Harris, Raymond C.
[J]. CELLS, 2022, 11 (21)
[47] Epithelial and endothelial mesenchymal transition and their role in diabetic kidney disease
Dadras, Farahnaz
Sheikh, Vida
Khoshjou, Farhad
[J]. JOURNAL OF RENAL INJURY PREVENTION, 2018, 7 (01): : 1 - 6
[48] Role of Acid-Base Homeostasis in Diabetic Kidney Disease
Pascale Khairallah
Julia J. Scialla
[J]. Current Diabetes Reports, 2017, 17
[49] ROLE OF INCRETIN BASED THERAPIES IN THE TREATMENT OF DIABETIC KIDNEY DISEASE
Fioretto, Paola
Frascati, Andrea
[J]. DIABETES MELLITUS, 2018, 21 (05): : 395 - 398
[50] Role of TRPC6 in Progression of Diabetic Kidney Disease
Alexander Staruschenko
Denisha Spires
Oleg Palygin
[J]. Current Hypertension Reports, 2019, 21

← 1 2 3 4 5 →